I don't know if that comment was intended to be in response to the concerns I raised - maybe I was purposefully not tagged - however the vagueness of 'mo cheaper = mo better" certainly didn't address the concern that MSB clinical potential has been scrutinised differently to headlines of literally everything else.Free speech is not of concern here buddy. The question is why, not what.
New Covid 19 treatment, page-277
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.040(3.88%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $4.767M | 4.464M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 116978 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 21098 | 21 |
View Market Depth
| Last trade - 14.43pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |